Board of Directors

The members of the Board of Directors comprise a group of professionally skilled business people representing a diversity and experience within animal health and life sciences, key competence areas for vaccine development. Current members are:
Newton Aguiar

Board member of Trialbee. Former senior health care advisor for Warburg Pincus and board member at Phadia, Nycomed, Grohe and Tetra Holdings.
Independent of
The company and its executives.

Independent of
major shareholders.

Bengt Guss
Bengt Guss

Professor at the Swedish University of Agricultural Sciences, Department of Biomedical Sciences and Veterinary Public Health.
Independent of
The company and its executives.

Independent of
major shareholders.

Marianne Hansson

CEO in start-ups ScandiBio Therapeutics AB, ScandiEdge Therapeutics AB and Amylonix AB. Former CEO at Atlas Antibodies AB
Independent of
The company and its executives.

Independent of
major shareholders.

Torben Jørgensen

President and CEO of Biotage AB. Former CEO at Affibody AB, Karo Bio AB and DAKO.
Independent of
The company and its executives.

Independent of
major shareholders.

Björn Sjöstrand

Chairman of the board, CEO Scandinavian Biopharma, former CEO of SBL Vaccin in Sweden, CEO of Swiss Berna Biotech and global head of the vaccines division of the Dutch company Crucell.
Independent of
The company and its executives.

Independent of
major shareholders.

Stefan Ståhl
Stefan Ståhl

Professor at the Royal Institute of Technology, department of molecular biotechology.
Independent of
The company and its executives.

Independent of
major shareholders.

Bert Urlings

DVM, Corporate Director Quality Assurance and Public Affairs at Vion Food, Board member International Featured Standards (IFS).
Independent of
The company and its executives.

Independent of
major shareholders.